Ignite Creation Date:
2025-12-25 @ 12:08 AM
Ignite Modification Date:
2026-05-25 @ 7:36 PM
Study NCT ID:
NCT05228158
Status:
RECRUITING
Last Update Posted:
2024-12-27
First Post:
2022-01-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Tazemetostat on Safety in Participants With Relapsed or Refractory Follicular Lymphoma With Enhancer of Zeste Homolog 2 (EZH2) Gene Mutation in Japan
Sponsor:
Eisai Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
E7438-M081-501
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None